Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Outcomes of Patients Treated With Vericiguat in German Routine Care

NCT06486844 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06486844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Outcomes of Patients Treated With Vericiguat in German Routine Care
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 5, 2024
Completion date
August 31, 2025
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure with reduced ejection fraction